GO:0008380 | RNA splicing | 3.69e-04 | 1.00e+00 | 4.302 | 3 | 21 | 165 |
GO:0010467 | gene expression | 9.00e-04 | 1.00e+00 | 3.020 | 4 | 49 | 535 |
GO:0004832 | valine-tRNA ligase activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0033182 | regulation of histone ubiquitination | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0035370 | UBC13-UEV1A complex | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0031058 | positive regulation of histone modification | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 9.78e-04 | 1.00e+00 | 5.383 | 2 | 8 | 52 |
GO:0033688 | regulation of osteoblast proliferation | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0031372 | UBC13-MMS2 complex | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0016574 | histone ubiquitination | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0036089 | cleavage furrow formation | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 4.15e-03 | 1.00e+00 | 4.329 | 2 | 2 | 108 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 5 |
GO:0043931 | ossification involved in bone maturation | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0005672 | transcription factor TFIIA complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0000729 | DNA double-strand break processing | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 5 |
GO:0042382 | paraspeckles | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 3 | 5 |
GO:0002181 | cytoplasmic translation | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 3 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 6 |
GO:0043297 | apical junction assembly | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 6 |
GO:0005654 | nucleoplasm | 5.61e-03 | 1.00e+00 | 2.309 | 4 | 68 | 876 |
GO:0016032 | viral process | 5.76e-03 | 1.00e+00 | 2.927 | 3 | 30 | 428 |
GO:0000398 | mRNA splicing, via spliceosome | 5.78e-03 | 1.00e+00 | 4.083 | 2 | 15 | 128 |
GO:0006301 | postreplication repair | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 7 |
GO:0006878 | cellular copper ion homeostasis | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0090307 | spindle assembly involved in mitosis | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0043296 | apical junction complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.01e-03 | 1.00e+00 | 3.753 | 2 | 18 | 161 |
GO:0001967 | suckling behavior | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 4 | 10 |
GO:0005736 | DNA-directed RNA polymerase I complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 4 | 10 |
GO:0050919 | negative chemotaxis | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 4 | 10 |
GO:0017025 | TBP-class protein binding | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 12 |
GO:0050772 | positive regulation of axonogenesis | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 14 |
GO:0006386 | termination of RNA polymerase III transcription | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 14 |
GO:0043393 | regulation of protein binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 14 |
GO:0070932 | histone H3 deacetylation | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 15 |
GO:0006281 | DNA repair | 1.41e-02 | 1.00e+00 | 3.418 | 2 | 24 | 203 |
GO:0032467 | positive regulation of cytokinesis | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 16 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 17 |
GO:0030054 | cell junction | 1.61e-02 | 1.00e+00 | 3.315 | 2 | 5 | 218 |
GO:0003899 | DNA-directed RNA polymerase activity | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 3 | 18 |
GO:0045739 | positive regulation of DNA repair | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 19 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 2.10e-02 | 1.00e+00 | 5.560 | 1 | 2 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 5 | 24 |
GO:0070534 | protein K63-linked ubiquitination | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 24 |
GO:0030901 | midbrain development | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 3 | 25 |
GO:0051496 | positive regulation of stress fiber assembly | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 4 | 27 |
GO:0050885 | neuromuscular process controlling balance | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 28 |
GO:0016881 | acid-amino acid ligase activity | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 3 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 6 | 29 |
GO:0042752 | regulation of circadian rhythm | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 5 | 29 |
GO:0043130 | ubiquitin binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 30 |
GO:0032154 | cleavage furrow | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 30 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.82e-02 | 1.00e+00 | 5.129 | 1 | 1 | 31 |
GO:0021762 | substantia nigra development | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 34 |
GO:0044822 | poly(A) RNA binding | 3.15e-02 | 1.00e+00 | 2.026 | 3 | 45 | 799 |
GO:0050434 | positive regulation of viral transcription | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 2 | 35 |
GO:0030900 | forebrain development | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 36 |
GO:0030334 | regulation of cell migration | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 36 |
GO:0005515 | protein binding | 3.44e-02 | 1.00e+00 | 0.881 | 7 | 198 | 4124 |
GO:0048511 | rhythmic process | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 6 | 40 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.72e-02 | 1.00e+00 | 2.670 | 2 | 23 | 341 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 4 | 42 |
GO:0000724 | double-strand break repair via homologous recombination | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 5 | 42 |
GO:0005634 | nucleus | 4.18e-02 | 1.00e+00 | 1.004 | 6 | 158 | 3246 |
GO:0005524 | ATP binding | 4.20e-02 | 1.00e+00 | 1.868 | 3 | 37 | 892 |
GO:0008203 | cholesterol metabolic process | 4.25e-02 | 1.00e+00 | 4.529 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 4.25e-02 | 1.00e+00 | 4.529 | 1 | 1 | 47 |
GO:0032481 | positive regulation of type I interferon production | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 48 |
GO:0000151 | ubiquitin ligase complex | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 4 | 48 |
GO:0006310 | DNA recombination | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 8 | 50 |
GO:0034146 | toll-like receptor 5 signaling pathway | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 3 | 50 |
GO:0034166 | toll-like receptor 10 signaling pathway | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 3 | 50 |
GO:0006289 | nucleotide-excision repair | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 3 | 53 |
GO:0003677 | DNA binding | 4.89e-02 | 1.00e+00 | 1.781 | 3 | 52 | 947 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 3 | 55 |
GO:0034162 | toll-like receptor 9 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 3 | 55 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 3 | 55 |
GO:0034134 | toll-like receptor 2 signaling pathway | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 3 | 56 |
GO:0042826 | histone deacetylase binding | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 5 | 58 |
GO:0000785 | chromatin | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 6 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 5 | 61 |
GO:0006464 | cellular protein modification process | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 4 | 61 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 4 | 61 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 6.01e-02 | 1.00e+00 | 4.017 | 1 | 5 | 67 |
GO:0050852 | T cell receptor signaling pathway | 6.10e-02 | 1.00e+00 | 3.996 | 1 | 2 | 68 |
GO:0045087 | innate immune response | 6.20e-02 | 1.00e+00 | 2.263 | 2 | 12 | 452 |
GO:0010951 | negative regulation of endopeptidase activity | 6.36e-02 | 1.00e+00 | 3.934 | 1 | 2 | 71 |
GO:0005829 | cytosol | 6.48e-02 | 1.00e+00 | 1.280 | 4 | 88 | 1787 |
GO:0030496 | midbody | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 6 | 73 |
GO:0016363 | nuclear matrix | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 10 | 73 |
GO:0034142 | toll-like receptor 4 signaling pathway | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 3 | 73 |
GO:0001649 | osteoblast differentiation | 6.62e-02 | 1.00e+00 | 3.874 | 1 | 5 | 74 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 6.79e-02 | 1.00e+00 | 3.836 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 6.88e-02 | 1.00e+00 | 3.817 | 1 | 6 | 77 |
GO:0030529 | ribonucleoprotein complex | 7.31e-02 | 1.00e+00 | 3.726 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 2 | 83 |
GO:0002224 | toll-like receptor signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 3 | 83 |
GO:0030027 | lamellipodium | 7.83e-02 | 1.00e+00 | 3.624 | 1 | 3 | 88 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 7.91e-02 | 1.00e+00 | 3.608 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 8.00e-02 | 1.00e+00 | 3.592 | 1 | 4 | 90 |
GO:0008201 | heparin binding | 8.08e-02 | 1.00e+00 | 3.576 | 1 | 4 | 91 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 8.17e-02 | 1.00e+00 | 3.560 | 1 | 6 | 92 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 9.44e-02 | 1.00e+00 | 3.342 | 1 | 5 | 107 |
GO:0006397 | mRNA processing | 9.70e-02 | 1.00e+00 | 3.302 | 1 | 12 | 110 |
GO:0003924 | GTPase activity | 1.05e-01 | 1.00e+00 | 3.189 | 1 | 7 | 119 |
GO:0006184 | GTP catabolic process | 1.14e-01 | 1.00e+00 | 3.061 | 1 | 7 | 130 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 1.15e-01 | 1.00e+00 | 3.039 | 1 | 2 | 132 |
GO:0030168 | platelet activation | 1.23e-01 | 1.00e+00 | 2.944 | 1 | 5 | 141 |
GO:0044212 | transcription regulatory region DNA binding | 1.24e-01 | 1.00e+00 | 2.924 | 1 | 13 | 143 |
GO:0019221 | cytokine-mediated signaling pathway | 1.48e-01 | 1.00e+00 | 2.657 | 1 | 10 | 172 |
GO:0007264 | small GTPase mediated signal transduction | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 8 | 174 |
GO:0000166 | nucleotide binding | 1.51e-01 | 1.00e+00 | 2.624 | 1 | 13 | 176 |
GO:0004842 | ubiquitin-protein transferase activity | 1.53e-01 | 1.00e+00 | 2.600 | 1 | 17 | 179 |
GO:0003713 | transcription coactivator activity | 1.57e-01 | 1.00e+00 | 2.560 | 1 | 21 | 184 |
GO:0016567 | protein ubiquitination | 1.61e-01 | 1.00e+00 | 2.529 | 1 | 14 | 188 |
GO:0005856 | cytoskeleton | 1.62e-01 | 1.00e+00 | 2.514 | 1 | 8 | 190 |
GO:0005525 | GTP binding | 1.68e-01 | 1.00e+00 | 2.461 | 1 | 12 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.69e-01 | 1.00e+00 | 2.447 | 1 | 8 | 199 |
GO:0008134 | transcription factor binding | 1.77e-01 | 1.00e+00 | 2.376 | 1 | 10 | 209 |
GO:0043234 | protein complex | 1.78e-01 | 1.00e+00 | 2.369 | 1 | 13 | 210 |
GO:0070062 | extracellular vesicular exosome | 1.81e-01 | 1.00e+00 | 0.988 | 3 | 51 | 1641 |
GO:0030198 | extracellular matrix organization | 1.86e-01 | 1.00e+00 | 2.296 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 1.92e-01 | 1.00e+00 | 2.244 | 1 | 4 | 229 |
GO:0007411 | axon guidance | 1.98e-01 | 1.00e+00 | 2.195 | 1 | 8 | 237 |
GO:0003723 | RNA binding | 2.06e-01 | 1.00e+00 | 2.135 | 1 | 22 | 247 |
GO:0046982 | protein heterodimerization activity | 2.19e-01 | 1.00e+00 | 2.034 | 1 | 11 | 265 |
GO:0006508 | proteolysis | 2.19e-01 | 1.00e+00 | 2.039 | 1 | 11 | 264 |
GO:0005925 | focal adhesion | 2.32e-01 | 1.00e+00 | 1.944 | 1 | 14 | 282 |
GO:0009986 | cell surface | 2.38e-01 | 1.00e+00 | 1.899 | 1 | 5 | 291 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.57e-01 | 1.00e+00 | 1.775 | 1 | 17 | 317 |
GO:0007596 | blood coagulation | 2.72e-01 | 1.00e+00 | 1.678 | 1 | 13 | 339 |
GO:0042802 | identical protein binding | 2.83e-01 | 1.00e+00 | 1.616 | 1 | 15 | 354 |
GO:0016020 | membrane | 3.08e-01 | 1.00e+00 | 0.846 | 2 | 56 | 1207 |
GO:0042803 | protein homodimerization activity | 3.32e-01 | 1.00e+00 | 1.342 | 1 | 13 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.50e-01 | 1.00e+00 | 1.251 | 1 | 29 | 456 |
GO:0005737 | cytoplasm | 4.54e-01 | 1.00e+00 | 0.306 | 3 | 127 | 2633 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.59e-01 | 1.00e+00 | 0.753 | 1 | 29 | 644 |
GO:0005739 | mitochondrion | 4.67e-01 | 1.00e+00 | 0.719 | 1 | 32 | 659 |
GO:0005886 | plasma membrane | 5.10e-01 | 1.00e+00 | 0.283 | 2 | 46 | 1784 |
GO:0006351 | transcription, DNA-templated | 6.50e-01 | 1.00e+00 | 0.012 | 1 | 47 | 1076 |
GO:0005730 | nucleolus | 6.98e-01 | 1.00e+00 | -0.166 | 1 | 74 | 1217 |
GO:0016021 | integral component of membrane | 7.83e-01 | 1.00e+00 | -0.492 | 1 | 19 | 1526 |